Clinical trial
Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
NCT00472563 · Universidad de Antioquia, Other · Completed
Key facts
| NCT number | NCT00472563 |
|---|---|
| Title | Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate |
| Official title | Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate |
| Acronym | PROMEC |
| Lead sponsor | Universidad de Antioquia, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Acute Kidney Failure |
| Intervention type | Drug |
| Interventions | Bicarbinate 150 mEq/L |
| Enrollment | 212 |
| Start date | May 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | May 11, 2007 |
| Last update posted | May 6, 2008 |
| Countries | Colombia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: